Intrinsic value of BioCryst Pharmaceuticals, Inc. (BCRX)
Live fair value data for BioCryst Pharmaceuticals, Inc. (BCRX) is currently unavailable. Please check again shortly.
Current Price: $43.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is BioCryst Pharmaceuticals, Inc. (BCRX) undervalued or overvalued?
Based on the current model output, BioCryst Pharmaceuticals, Inc. appears to be undervalued with a upside of 11.00%.
Fair value vs market price — BioCryst Pharmaceuticals, Inc. (BCRX)
Unlock premium access to view the live fair value comparison against current market price for BCRX.
Frequently Asked Questions - BCRX
How is BCRX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BCRX.
Is BCRX undervalued or overvalued right now?
BCRX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BCRX: open their intrinsic value pages.